Why the study?
Does trivalent oral poliovirus vaccine improve seroconversion in institutionalized children with varying immunity to poliomyelitis?
Does trivalent oral poliovirus vaccine improve seroconversion in institutionalized children with varying immunity to poliomyelitis?
Trivalent oral poliovirus vaccine effectively induces seroconversion in institutionalized children, though the type 1 component may be less effective in those with very low baseline immunity to all types.
May support single-dose TOPV in partially immune children; leaves open type 1 efficacy at very low baseline titers pending trials.
Ninety-one children in an orphanage, who had varying degrees of natural and acquired immunity to polioviruses, were given three doses of a trivalent poliovirus vaccine at monthly intervals. It was found that among children who lacked protection to one or two types, a single dose of trivalent vaccine resulted in seroconversion to that type. For those who had antibody levels of less than four to all three types, the type 1 component of the vaccine appeared to be less effective than the other two types. An elevation in serum antibody titer was noted more frequently in children who had preimmunization titers of 1:64 or less than in those with high preimmunization titers. Although the mechanism of acquisition of prior immunity was unknown, it must be assumed that many of the subjects had had natural poliovirus infection in the past.
No takes yet. Share an insight, caveat, or question.
Lepow et al. (1965) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: